Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers

Michael Freundlich1, Evelyn Alonzo, Ezequiel Bellorin-Font

  • 1University of Miami School of Medicine, Miami, Florida, USA. mfmefex@pol.net

Insights

Idiopathic hypercalciuria (IH) in children is linked to reduced bone mineral density (BMD), potentially starting early in life. This study found low BMD in many children with IH and their mothers, suggesting a genetic link and future osteoporosis risk.

Area of Science:

  • Pediatric Endocrinology
  • Bone Metabolism
  • Nephrology

Background:

  • Idiopathic hypercalciuria (IH) and nephrolithiasis are associated with reduced bone mineral density (BMD).
  • Previous BMD studies in IH patients primarily focused on adults, with a lack of research in North American children.
  • Optimal bone health during childhood is crucial for achieving peak bone mass and preventing future skeletal issues.

Purpose of the Study:

  • To evaluate bone mineral metabolism in children with IH and their asymptomatic mothers.
  • To investigate potential genetic influences on bone health in families with IH.
  • To assess BMD and related factors in a pediatric population with idiopathic hypercalciuria.

Main Methods:

  • Quantitative bone mineral density (BMD) assessment using dual-energy X-ray absorptiometry (DEXA) in 21 children with IH and their mothers.
  • Measurement of urinary bone resorption markers (pyridinoline and deoxypyridinoline).
  • Determination of calcium-modulating hormones (parathyroid hormone, 1,25(OH)(2)D(3)) and interleukin-1alpha (IL-1alpha) expression in peripheral blood mononuclear cells (PBMCs).

Main Results:

  • Reduced BMD was observed in 38% of children and 33% of mothers.
  • Children of mothers with osteopenia had significantly lower lumbar spine BMD Z-scores.
  • Hypercalciuria was present in 25% of mothers and correlated with reduced femoral BMD in osteopenic mothers.

Conclusions:

  • A significant proportion of children with idiopathic hypercalciuria exhibit reduced bone mineral density.
  • Reduced BMD and hypercalciuria can be present in asymptomatic mothers, suggesting early onset and potential genetic factors.
  • Diminished BMD in IH may originate in childhood, posing a risk for future osteoporosis.
Abstract

Related Concept Videos

Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...